Connect with us

Business

Nifty Earnings Expected To Grow 16% In FY27: Report

Published

on

Nifty Earnings Expected To Grow 16% In FY27: Report


New Delhi: The average earnings from Nifty 50 companies are expected to grow 8 per cent in FY26 and 16 per cent in FY27, driven by policy measures, macro resilience, and a maturing domestic investor base, a report said on Thursday. As India’s markets enter Samvat 2082, the Motilal Oswal Financial Services Ltd (MOFSL) report said that it is positive on BFSI, capital markets, consumption, manufacturing, and digital sectors.

The broking firm noted policy measures that increased liquidity and demand, such as a 100-basis-point repo cut, a 150-basis-point CRR reduction, Rs 1 lakh crore in income tax relief, GST 2.0 reforms, and reduced inflation, have improved consumer sentiment.

“We believe this marks the beginning of a turnaround in India’s domestic growth momentum, with a significant pickup in consumption paving the way for a robust revival in the private capex cycle. This, along with the improving earnings trajectory, should lend support to Indian equities,” the report said.

Add Zee News as a Preferred Source


Motilal Oswal said that these tailwinds support a forecast for a shift from single-digit earnings growth to sustainable double-digit growth in the second half of FY26. “The underlying fundamentals have strengthened – supported by a 7.8 per cent GDP growth in Q1FY26, easing inflation at 1.5 per cent in September 2025 compared to 5.5 per cent in September 2024, and a supportive policy environment that continues to boost investor confidence,” it said.

Valuations are reasonable and close to long-term averages at approximately 20 times FY26 earnings. Mid and small caps are trading at a slight premium, indicating a need for selective stock picking, the brokerage said. Financials are set for earnings recovery in H2FY26, aided by lower borrowing costs, improving NIMs, and steady deposits, the brokerage firm said. Capex revival and policy reforms should drive multiyear growth for the manufacturing sector, positioning India as a key global manufacturing hub, the report noted.



Source link

Business

Could a digital twin make you into a ‘superworker’?

Published

on

Could a digital twin make you into a ‘superworker’?



Firms say digital twins make staff more productive, but are they a potential legal minefield?



Source link

Continue Reading

Business

Netflix co-founder Reed Hastings to step down as chairman

Published

on

Netflix co-founder Reed Hastings to step down as chairman



Hastings set up the company in 1997, when it rented DVDs to customers and delivered by post.



Source link

Continue Reading

Business

Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy

Published

on

Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy


Rear Admiral Erica G. Schwartz.

U.S. Department of Health and Human Services

President Donald Trump on Thursday nominated Erica Schwartz to serve as director of the Centers for Disease Control and Prevention, concluding a monthslong effort to choose a permanent leader of the embattled health agency. 

Schwartz, who will have to be confirmed by the Senate, would take over the role as Health and Human Services Secretary Robert F. Kennedy Jr. oversees a string of controversial health policy changes at the agency, including an overhaul of childhood vaccine recommendations.

Schwartz served as deputy surgeon general during the first Trump administration, where she played a major role in the U.S. response to the Covid-19 pandemic. She spent more than 20 year in uniform, including as rear admiral and chief medical officer of the Coast Guard.

Dr. Jay Bhattacharya had been acting director of the CDC — a title that expired last month under federal law. That law, called the Vacancies Act, limits the amount of time an acting officer can serve in place of a Senate-confirmed official to 210 days. 

Late last month marked 210 days since the most recent CDC director, Dr. Susan Monarez, was fired

A sign sits outside of the Centers for Disease Control and Prevention (CDC) Roybal campus in Atlanta, Georgia, U.S. March 18, 2026.

Megan Varner | Reuters

She has so far been the only person to serve as a confirmed CDC director during Trump’s second term, holding the role for under a month last summer. In congressional testimony in September, Monarez said she was fired after refusing Kennedy’s demands to approve vaccine recommendations she believed lacked scientific support.

It is unclear how Schwartz’s views on vaccines or other key public health policies compare with Kennedy’s.

Also on Thursday, Trump said he chose Sean Slovenski as deputy CDC director and chief operating officer, and Jennifer Shuford as deputy CDC director and chief medical officer. Shuford, as head of the Texas Department of State Health Services, led the state’s response to a massive measles outbreak last year, and credited vaccination and testing in declaring it over.

Schwartz’s nomination comes after a tumultuous several months for the agency, which is reeling from the leadership upheaval, plummeting morale, significant staff turnover and controversial changes to U.S. vaccine policy. Ahead of leadership departures last year, staff members were shaken by a gunman’s attack on the CDC’s Atlanta headquarters on Aug. 8. 

Last month, a judge blocked a critical vaccine panel’s efforts to overhaul U.S. immunization policy. That includes an effort to reduce the number of recommended childhood shots from 17 to 11.

Trust in federal health agencies has plummeted during Kennedy’s tenure as Health and Human Services secretary, according to a February poll from health policy research group KFF, with declines across the political spectrum.

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.



Source link

Continue Reading

Trending